Prometheus Laboratories has launched a serum/antibody test for inflammatory bowel disease (IBD), and a serum test for Crohn's disease,
Among the 76 newly discovered mutations are several that provide bacteria with the ability to degrade carbapanems, a class of antibiotics.
This webinar explores the complexity of diagnostic testing in immuno-oncology and therapeutic innovations that have emerged in the field.
Martin Tolar, Founder
President & CEO, Alzheon